Sterling Consolidated Corp. STCC
Last Post: 11/29/2018 11:18:53 AM
Board Marks: 4
Posts Today: 0
Board Views Today: 190
10/10/2013 8:39:05 AM
10/10/2013 8:39:00 AM
10/10/2013 8:38:54 AM
10/10/2013 8:35:18 AM
10/10/2013 8:32:48 AM
10/10/2013 8:32:43 AM
10/10/2013 8:32:36 AM
10/10/2013 8:30:07 AM
10/10/2013 8:11:08 AM
10/10/2013 7:43:48 AM
10/10/2013 6:54:03 AM
10/10/2013 6:23:50 AM
10/10/2013 6:16:33 AM
10/09/2013 9:11:29 PM
10/03/2013 12:36:28 PM
10/03/2013 12:36:01 PM
10/03/2013 9:58:35 AM
10/03/2013 9:54:56 AM
10/03/2013 9:53:29 AM
10/03/2013 9:51:46 AM
10/03/2013 9:49:58 AM
10/03/2013 9:48:24 AM
10/03/2013 9:46:50 AM
10/03/2013 9:34:52 AM
10/03/2013 9:32:24 AM
10/03/2013 8:47:12 AM
10/03/2013 8:45:17 AM
10/03/2013 8:40:33 AM
10/03/2013 8:38:30 AM
10/03/2013 8:36:43 AM
10/03/2013 8:34:54 AM
10/03/2013 8:33:02 AM
10/03/2013 8:31:36 AM
10/03/2013 8:29:59 AM
10/02/2013 3:15:22 PM
10/02/2013 1:58:55 PM
10/02/2013 1:57:21 PM
10/02/2013 1:55:41 PM
10/02/2013 1:54:02 PM
10/02/2013 1:51:49 PM
10/01/2013 11:35:25 AM
10/01/2013 11:20:27 AM
10/01/2013 11:13:01 AM
10/01/2013 11:03:45 AM
10/01/2013 10:55:07 AM
10/01/2013 10:40:46 AM
10/01/2013 10:37:51 AM
10/01/2013 10:32:18 AM
10/01/2013 10:12:54 AM
10/01/2013 10:06:03 AM
Recent Articles
- SKYWORTH Launches Revolutionary Matte Screen Ultra TV Series
- Exciting Advances in Lung Cancer Treatment with Sacituzumab Tirumotecan
- MoonLake Immunotherapeutics: A Call to Action for Investors
- Investors Urged to Act Quickly in PubMatic Class Action Suit
- Tragic Cargo Plane Incident at Hong Kong Airport Sparks Concerns
- Christine Lagarde's Insight: Upcoming Tariff Effects on U.S. Consumers
- Insights on the Upcoming Financial Street Forum in Beijing
- Antengene Advances ATG-022: Promising Clinical Outcomes Revealed
- Investigation Announcement for Baxter International Investors
- Cytokinetics Investors: Secure Representation Before Deadline
- Jasper Therapeutics Investors: Important Class Action Deadline Ahead
- Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
- CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
- Ascletis Completes Enrollment in Phase IIa Study of ASC30.
- Innovations in Pancreatic Cancer Treatment with Satri-cel
- Cambodia's Techo International Airport: A Gateway to Growth
- Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
- Faraday Future's Vision: Accelerating Towards FX Super One Launch
- IZERVAY™ Delivers Long-Term Benefits for Geographic Atrophy Patients
- Clover Biopharmaceuticals Names Nicholas Jackson as President
- Dr. Luke Wainscoat Brings Expertise to The Brattle Group
- Kering and L'Oréal Unite to Transform Luxury Beauty Sector
- Kering and L’Oréal: A New Era in Luxury Beauty and Wellness
- Kering Partners with L'Oréal to Transform Luxury Beauty Sector
- Alice Walton and Elon Musk: Giants of Wealth in 2025
- Clarins and V Magazine Host a Glamorous Golden Hour Event
- Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
- Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
- Exploring NB HASH and the Transformation of Wealth Today
- Kevin Hart's Journey From Investment Missteps to Business Success
- BlackRock's Strategic Shift: The Future of Investment in RWA
- Major Contract Termination Announced by Vantage Drilling
- Deadline Approaches for Dow Inc. Investors Amid Legal Action
- Important Update for Cepton, Inc. Investors on Class Action
- Target and Walmart Thrive Amid Collectible Card Sales Surge
- Snap Investors Urged to Consider Leading Legal Action
- Unlocking Wealth Potential: The RWA Revolution Explained
- Embracing Real-World Assets with NB HASH for Sustainable Growth
- Nutex Health Investors Can Join Class Action Against Company
- Potential Legal Action for Baxter International Investors
- Solidarity in Aviation: Airline Workers Support Controllers
- Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
- Promising Outcomes Unveiled from HARMONi-6 Clinical Study
- Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
- Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
- Promising Findings on Subcutaneous Amivantamab for Cancer
- Vivace Therapeutics Reports Promising Results for VT3989 Therapy
- iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
- Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
- New Breakthrough Data from Novartis on Prostate Cancer Treatment
